Lam Research CEO Archer sells 31,400 shares
The report also lists 48,026 shares held indirectly through Archer’s 401(k) and 5,670 through his spouse’s 401(k).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lam Research Corp. President and CEO Timothy Archer exercised options to acquire 31,400 shares of common stock at $30.0330 per share on October 23, 2026, then sold 31,400 shares at $227.0200 per share that day. The acquisition and sale were effected pursuant to a Rule 10b5-1 trading plan adopted February 24, 2026. The reported share amounts include shares subject to unvested restricted stock units.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) F3 | 31,400 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 31,400 | $30.033 | $943K |
| Sale | Common Stock F1, F2 | 31,400 | $227.02 | $7.13M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2026.
- F2. The amount reported includes shares subject to unvested restricted stock units.
- F3. The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
restricted stock units financial
Employee Stock Option (Right to Buy) financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Did Timothy Archer exercise LRCX options?
AI-generated analysis. How Rhea-AI works. Not financial advice.